TOP HEADLINES

FEATURED STORY

WuXi reaches into the biopharma hubs of Boston and San Francisco

WuXi PharmaTech, China's largest CRO, is blueprinting forays into two of the hottest locales for U.S. R&D, planning to open offices in Boston and San Francisco.

PPD partners up with ERT for data collection

PPD has signed a data-minded deal with the collection experts at ERT, a partnership the companies believe will help their clients conduct more efficient trials.

After CEO's death, Health Decisions brings in a Quintiles vet to lead its transition

Health Decisions, a week removed from the plane crash that claimed the life of its CEO, has recruited a CRO veteran from the University of North Carolina to step in as interim chief executive and oversee its transition.

BioClinica snags a Pfizer exec to take the helm

BioClinica, fresh from its latest merger, has named a Pfizer executive as its next CEO.

CRO Health Decisions carries on after CEO's death

North Carolina CRO Health Decisions is working its way back to normalcy after the death of its founder and CEO, processing a loss that "devastated" its staff, an executive said.

MORE NEWS

From Our Sister Sites

FierceBiotech

AbbVie won an expected FDA approval for its next-generation treatment for hepatitis C, kicking off a race with Gilead Sciences for dominance in a blockbuster field.

FierceDiagnostics

Myriad Genetics won FDA approval for its companion diagnostic test for AstraZeneca's ovarian cancer drug Lynparza, giving the company a boost as it recoups from its latest patent battle loss and helping it gain ground in a fast-growing market.